FDA Approves Convalescence Plasma Treatment For COVID-19 Patients

The Food and Drugs Authority (FDA) has approved an investigational convalescent plasma collected from individuals who have recovered from COVID-19 for the treatment of critically ill COVID-19 patients.

 
Recipient Email: *
 
Your name: *
Your Email: *